246 related articles for article (PubMed ID: 35004850)
1. An Unfolded Protein Response Related Signature Could Robustly Predict Survival Outcomes and Closely Correlate With Response to Immunotherapy and Chemotherapy in Bladder Cancer.
Zhang F; Feng D; Wang X; Gu Y; Shen Z; Yang Y; Wang J; Zhong Q; Li D; Hu H; Han P
Front Mol Biosci; 2021; 8():780329. PubMed ID: 35004850
[No Abstract] [Full Text] [Related]
2. Development and Validation of a Hypoxia-Related Signature for Predicting Survival Outcomes in Patients With Bladder Cancer.
Zhang F; Wang X; Bai Y; Hu H; Yang Y; Wang J; Tang Y; Ma H; Feng D; Li D; Han P
Front Genet; 2021; 12():670384. PubMed ID: 34122523
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive
Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
Front Immunol; 2022; 13():931906. PubMed ID: 35958598
[TBL] [Abstract][Full Text] [Related]
4. Integrative transcriptional characterization of cell cycle checkpoint genes promotes clinical management and precision medicine in bladder carcinoma.
Shi WW; Guan JZ; Long YP; Song Q; Xiong Q; Qin BY; Ma ZQ; Hu Y; Yang B
Front Oncol; 2022; 12():915662. PubMed ID: 36033441
[TBL] [Abstract][Full Text] [Related]
5. Identification of a novel signature based on unfolded protein response-related gene for predicting prognosis in bladder cancer.
Zhu K; Xiaoqiang L; Deng W; Wang G; Fu B
Hum Genomics; 2021 Dec; 15(1):73. PubMed ID: 34930465
[TBL] [Abstract][Full Text] [Related]
6. Unfolded protein response signature unveils novel insights into breast cancer prognosis and tumor microenvironment.
Zhou N; Kong D; Lin Q; Yang X; Zhou D; Lou L; Huang F
Cancer Genet; 2023 Aug; 276-277():17-29. PubMed ID: 37343507
[TBL] [Abstract][Full Text] [Related]
7. Identification of an unfolded protein response-related signature for predicting the prognosis of pancreatic ductal adenocarcinoma.
Fang L; Chen S; Gong H; Xia S; Guan S; Quan N; Li Y; Zeng C; Chen Y; Du J; Liu S
Front Oncol; 2022; 12():1060508. PubMed ID: 36727081
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Benefits and Prognostic Value of a Model Based on 7 Immune-associated Genes in Bladder Cancer.
Cao M; Cao Y; Xue S; Zhang Q; Zhang H; Xue W
Altern Ther Health Med; 2024 Apr; 30(4):130-138. PubMed ID: 38518167
[TBL] [Abstract][Full Text] [Related]
9. A novel immune checkpoint-related seven-gene signature for predicting prognosis and immunotherapy response in melanoma.
Tian M; Yang J; Han J; He J; Liao W
Int Immunopharmacol; 2020 Oct; 87():106821. PubMed ID: 32731180
[TBL] [Abstract][Full Text] [Related]
10. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
11. A hypoxia related long non-coding RNA signature could accurately predict survival outcomes in patients with bladder cancer.
Zhang F; Wang X; Hu H; Yang Y; Wang J; Tang Y; Li D; Bai Y; Han P
Bioengineered; 2021 Dec; 12(1):3802-3823. PubMed ID: 34281486
[TBL] [Abstract][Full Text] [Related]
12. Identifying the Role of Oxidative Stress-Related Genes as Prognostic Biomarkers and Predicting the Response of Immunotherapy and Chemotherapy in Ovarian Cancer.
Liu Q; Yang X; Yin Y; Zhang H; Yin F; Guo P; Zhang X; Sun C; Li S; Han Y; Yang Z
Oxid Med Cell Longev; 2022; 2022():6575534. PubMed ID: 36561981
[TBL] [Abstract][Full Text] [Related]
13. A novel immune-related gene pair prognostic signature for predicting overall survival in bladder cancer.
Fu Y; Sun S; Bi J; Kong C; Yin L
BMC Cancer; 2021 Jul; 21(1):810. PubMed ID: 34266411
[TBL] [Abstract][Full Text] [Related]
14. Development and Validation of a Six-Gene Prognostic Signature for Bladder Cancer.
Xu F; Tang Q; Wang Y; Wang G; Qian K; Ju L; Xiao Y
Front Genet; 2021; 12():758612. PubMed ID: 34938313
[TBL] [Abstract][Full Text] [Related]
15. Pyroptosis-Related Gene to Construct Prognostic Signature and Explore Immune Microenvironment and Immunotherapy Biomarkers in Bladder Cancer.
Zhang X; Liang H; Tang Q; Chen H; Guo F
Front Genet; 2022; 13():801665. PubMed ID: 35846123
[TBL] [Abstract][Full Text] [Related]
16. A New Ferroptosis-Related lncRNA Signature Predicts the Prognosis of Bladder Cancer Patients.
Chen M; Nie Z; Li Y; Gao Y; Wen X; Cao H; Zhang S
Front Cell Dev Biol; 2021; 9():699804. PubMed ID: 34869304
[No Abstract] [Full Text] [Related]
17. An inflammation-related signature could predict the prognosis of patients with kidney renal clear cell carcinoma.
Yu Q; Zhang F; Feng D; Li D; Xia Y; Gan MF
Front Genet; 2022; 13():866696. PubMed ID: 36035192
[No Abstract] [Full Text] [Related]
18. Tumor Expression Profile Analysis Developed and Validated a Prognostic Model Based on Immune-Related Genes in Bladder Cancer.
Dong B; Liang J; Li D; Song W; Zhao S; Ma Y; Song J; Zhu M; Yang T
Front Genet; 2021; 12():696912. PubMed ID: 34512722
[No Abstract] [Full Text] [Related]
19. Prognostic Signature Development on the Basis of Macrophage Phagocytosis-Mediated Oxidative Phosphorylation in Bladder Cancer.
Qu G; Xu Y; Lu Z; Nie H; Tang C; Hou J; Wen X
Oxid Med Cell Longev; 2022; 2022():4754935. PubMed ID: 36211821
[TBL] [Abstract][Full Text] [Related]
20. Construction and External Validation of a Ferroptosis-Related Gene Signature of Predictive Value for the Overall Survival in Bladder Cancer.
Liu J; Ma H; Meng L; Liu X; Lv Z; Zhang Y; Wang J
Front Mol Biosci; 2021; 8():675651. PubMed ID: 34095228
[No Abstract] [Full Text] [Related]
[Next] [New Search]